1.
Oncoimmunology
; 5(9): e1213935, 2016.
Artículo
en Inglés
| MEDLINE
| ID: mdl-27757310
RESUMEN
When naive mice receive short Zfra peptides via tail vein injections, they develop lifetime resistance to growth of many cancer xenografts, due to activation of a novel spleen memory Hyal-2+ CD3- CD19- Z lymphocyte. In vitro education of spleen cells with Zfra activates Z cell for conferring memory anticancer response in vivo.